Amputation Risks from Invokana Questioned in Study By Manufacturer
A new study by the makers of Invokana claim that the diabetes drug’s side effects do not cause any higher rates of lower limb amputation than similar diabetes drugs.…
«
»
A new study by the makers of Invokana claim that the diabetes drug’s side effects do not cause any higher rates of lower limb amputation than similar diabetes drugs.…
Rates of hospitalization due to diabetic ketoacidosis are on the rise in recent years, and Invokana and similar drugs may be contributing to that increase, according to the CDC.…
A product liability lawsuit indicates that the side effects of Farxiga and Xigduo XR led to an Indiana man suffering diabetic ketoacidosis and acute kidney injury.…
Doctors are questioning the ethics of giving diabetes patients placebos when they expect to be taking drugs that would help them control their condition.…
Invokana’s control over the SGLT2 diabetes drug market is slipping as Jardiance gains, touting better heart benefits and appearing to lack Invokana amputation risks.…
A new study highlights the diabetic ketoacidosis risk with Invokana, indicating that users of the new generation diabetes drug may be twice as likely to develop this dangerous build up of acid levels in the blood.…
A number of diabetes drug manufacturers have been named in a wrongful death lawsuit indicating that drugs like Invokana, Farxiga and Jardiance caused a Kentucky man to die of respiratory failure and kidney failure.…
European drug regulators have issued recommendations calling for immediate treatment if signs of Invokana diabetic ketoacidosis are present, warning that they may go undetected.…
Researchers say doctors can predict and prevent incidents of Invokana diabetic ketoacidosis through careful monitoring.…
A conference scheduled for this fall will look at the risks of diabetic ketoacidosis recently linked to Invokana and similar diabetes drugs.…